Cargando…
The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis
OBJECTIVE: To date, there are several published studies on the value of IDH-1 (isocitrate dehydrogenase-1) mutation and MGMT (O6-Methylguanine-DNA methyltransferas) promoter methylated status on the diagnosis of pseudoprogression (PSP) and true tumor progression after or within chemo-radiotherapy of...
Autores principales: | Zhou, Min, Niu, Chaoshi, Jia, Li, He, Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922590/ https://www.ncbi.nlm.nih.gov/pubmed/31852075 http://dx.doi.org/10.1097/MD.0000000000018194 |
Ejemplares similares
-
Accuracy of ADC derived from DWI for differentiating high-grade from low-grade gliomas: Systematic review and meta-analysis
por: Wang, Qiang-ping, et al.
Publicado: (2020) -
Retrospective examination of pseudoprogression in IDH mutant gliomas
por: Wetzel, Ethan A, et al.
Publicado: (2023) -
The prognostic value of tumor-associated macrophages in glioma patients
por: Shen, Yang, et al.
Publicado: (2023) -
Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019) -
IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
por: Yang, Pei, et al.
Publicado: (2015)